Global Helicobacter Pylori Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Helicobacter Pylori Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Helicobacter pylori (H. pylori) is a Gram-negative, microaerobic human pathogen and H. pylori infection is strongly related with many gastroduodenal diseases including chronic active gastritis, peptic ulcer diseases, atrophic gastritis, mucosa associated lymphoid tissue (MALT) lymphoma and noncardia gastric cancer. H. pylori infection affects more than half of the adult population worldwide, but the prevalence of H pylori infection varies widely by geographic area, age, race, and socioeconomic status. Usually, the prevalence of H. pylori increases with age in most countries, however a decline in prevalence of H. pylori infection has been observed in recent decades in time trend analysis of several large populations. More than 80% of peptic ulcer diseases are caused by H. pylori infection and the estimated lifetime risk for peptic ulcer disease in H. pylori-infected patients is approximately 15%. Gastric cancer is the third leading cause of cancer-related death worldwide and H. pylori infection is responsible for 74.7% of all noncardia gastric cancer cases. Gastric cancer and peptic ulcer together cause more than a million deaths per year in the world and H. pylori infection always is an important health issue. Various diagnostic methods are developed to detect H. pylori infection and diagnostic tests with both high sensitivity and specificity, exceeding 90%, are necessary for accurate diagnosis of H. pylori infection in clinical practice. Although many diagnostic tests are available now, each method has its own advantages, disadvantages, and limitations. The choice of one method or another could be depended on availability and accessibility of diagnostic tests, level of laboratories, clinical conditions of patients, and likelihood ratio of positive and negative tests on different clinical circumstances. Diagnostic tests are usually divided into invasive (endoscopic-based) and noninvasive methods. Invasive diagnostic tests include endoscopic image, histology, rapid urease test, culture, and molecular methods. Non-invasive diagnostic tests included Non-invasive Techniques, stool antigen test, serological, and molecular examinations. In the present report, we mainly studies the Helicobacter pylori diagnostic reagent or test box market status and outlook of global and major regions, from angles of players, regions, product and end Application/industries; this report analyzes the top players in global and major regions, and splits the Helicobacter Pylori Diagnostics market by product and Application/end industries.

According to our (Global Info Research) latest study, the global Helicobacter Pylori Diagnostics market size was valued at US$ 708 million in 2023 and is forecast to a readjusted size of USD 1141 million by 2030 with a CAGR of 7.1% during review period.

Global Helicobacter Pylori Diagnostics key players include Sekisui Diagnostics, Medline Industries, F. Hoffmann-La Roche, Meridian Bioscience, Bio-Rad Laboratories, etc. Global top five manufacturers hold a share about 85%. Europe is the largest market, with a share about 30%, followed by Asia-Pacific and North America, both with a share about 25 percent. In terms of product, Non-invasive Techniques is the largest segment, with a share about 80%. And in terms of application, the largest application is Hospitals and Clinics, followed by Diagnostic Laboratories, etc.

This report is a detailed and comprehensive analysis for global Helicobacter Pylori Diagnostics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global Helicobacter Pylori Diagnostics market size and forecasts, in consumption value ($ Million), 2019-2030

Global Helicobacter Pylori Diagnostics market size and forecasts by region and country, in consumption value ($ Million), 2019-2030

Global Helicobacter Pylori Diagnostics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030

Global Helicobacter Pylori Diagnostics market shares of main players, in revenue ($ Million), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Helicobacter Pylori Diagnostics

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Helicobacter Pylori Diagnostics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sekisui Diagnostics, F. Hoffmann-La Roche, Medline Industries, Meridian Bioscience, Bio-Rad Laboratories, Thermo Fisher Scientific, Alpha Laboratories, EKF Diagnostics, Quidel, Halyard Health, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation

Helicobacter Pylori Diagnostics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segmentation

Helicobacter Pylori Diagnostics market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Invasive Techniques
Non-invasive Techniques

Market segment by Application
Hospitals and Clinics
Diagnostic Laboratories
Others

Market segment by players, this report covers
Sekisui Diagnostics
F. Hoffmann-La Roche
Medline Industries
Meridian Bioscience
Bio-Rad Laboratories
Thermo Fisher Scientific
Alpha Laboratories
EKF Diagnostics
Quidel
Halyard Health
Cardinal Health
Beckman Coulter
Agilent Technologies
Coris BioConcept

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Helicobacter Pylori Diagnostics product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Helicobacter Pylori Diagnostics, with revenue, gross margin, and global market share of Helicobacter Pylori Diagnostics from 2019 to 2024.

Chapter 3, the Helicobacter Pylori Diagnostics competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Helicobacter Pylori Diagnostics market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Helicobacter Pylori Diagnostics.

Chapter 13, to describe Helicobacter Pylori Diagnostics research findings and conclusion.